CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 22 enrolled
Drug / intervention
800mg OZ439 prototype formulation 1 +3 moredrug
Likely dose
800mg OZ439 prototype formulation 1from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02083406
NCT02083406Phase 1Completed
CompareCT.gov

Open Label Study to Investigate the Pharmacokinetics of Prototype Formulations of OZ439 Administered With Piperaquine Phosphate in the Fasted State to Healthy Subjects

Medicines for Malaria Venture·interventional·Posted Mar 11, 2014·Updated Mar 23, 2015

In Brief

A Phase 1 clinical trial evaluating 800mg OZ439 prototype formulation 1, 800mg OZ439 prototype formulation 2, and 2 other interventions for Malaria. Completed, enrolled 22 participants across 1 site.

Detailed Summary

A single dose study to investigate how different formulations of OZ439 co-administered with PQP tablest are processed by the body when taken without food

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria
CountriesUnited Kingdom
CollaboratorsQuotient Clinical

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 11, 2014
Enrollment StartJul 1, 2014
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 12.3 years ago

Interventions

800mg OZ439 prototype formulation 1drug

800mg OZ439 prototype formulation 2drug

800mg OZ439 prototype formulation 3drug

960mg PQPdrug